Persistent Hypotension is determined by hypotension that persists in the hour after the conclusion of the 30 ml/kg Crystalloid Fluid Administration: The end time of the fluid administration must be determined. This may be clearly documented in the chart or may need to be calculated by the abstractor. Review the systolic blood pressure readings and mean arterial pressure readings (MAP) beginning at the end time of…
Looking for support for your program? Interested in working for Registry Partners Oncology Division? We would love the opportunity to meet you face-to-face and speak with you about your individual needs! Stop by and see us at the following conferences next week! (CRANE) Cancer Registrars Association of New England – Annual Regional Conference October 24 & 25, 2016 DoubleTree by Hilton, Portland, Maine Click here for more…
Theresa Real, RHIT, CTR, Project Manager for the Registry Partners Oncology Division attended the New York and Pennsylvania Cancer Registrars Associations Regional Conference last week and was kind enough to share her experience at this amazing conference! “The 2016 Regional Educational Conference was held in gorgeous Fairport, NY October 12th-October 14th. This regional educational conference was a first time partnership between New York Cancer Registrar’s Association and Pennsylvania Association…
As with Severe Sepsis, Septic Shock presentation can be determined based on provider documentation OR on clinical indicators. To determine the presentation of septic shock: First you MUST have Severe Sepsis Second you MUST have EITHER An Initial Lactate Level >=4 {if the lactate level is the last indicator use result time} OR Hypotension prior to crystalloid fluid administration and hypotension that persists within one hour…
